These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14702618)

  • 1. FasL, leukocytes and vascular modeling.
    Ferguson TA; Stuart PM
    Nat Med; 2004 Jan; 10(1):12; author reply 13. PubMed ID: 14702618
    [No Abstract]   [Full Text] [Related]  

  • 2. Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients.
    Kotani N; Fukuo K; Yasuda O; Sugimoto K; Katuya T; Takemura Y; Kawamoto H; Yokoi T; Suzuki A; Ogihara T
    Hypertens Res; 2006 Apr; 29(4):217-25. PubMed ID: 16778328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q; Nakadai A; Takeda K; Kawada T
    Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
    Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
    Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
    Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
    Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.
    Modiano JF; Sun J; Lang J; Vacano G; Patterson D; Chan D; Franzusoff A; Gianani R; Meech SJ; Duke R; Bellgrau D
    Clin Immunol; 2004 Jul; 112(1):54-65. PubMed ID: 15207782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Fas-FasL in insulitis in nonobese diabetic mouse.
    Cao JY; Wang H
    Chin Med J (Engl); 2004 Apr; 117(4):615-7. PubMed ID: 15109461
    [No Abstract]   [Full Text] [Related]  

  • 9. CTLA-4.FasL inhibits allogeneic responses in vivo.
    Dranitzki-Elhalel M; Huang JH; Rachmilewitz J; Pappo O; Parnas M; Schmidt W; Tykocinski ML
    Cell Immunol; 2006 Feb; 239(2):129-35. PubMed ID: 16828466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
    Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
    J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
    Ryan AE; Shanahan F; O'Connell J; Houston AM
    Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of apoptotic Fas ligand-expressing tumors decreased antitumor responses by enhanced production of immunosuppressive cytokines.
    Wada A; Tada Y; Shimozato O; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
    Anticancer Res; 2005; 25(1A):299-303. PubMed ID: 15816551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure.
    Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H
    Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Fas ligand as an effector molecule in corneal graft rejection.
    Stuart PM; Yin X; Plambeck S; Pan F; Ferguson TA
    Eur J Immunol; 2005 Sep; 35(9):2591-7. PubMed ID: 16114107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis.
    Engelbert M; Gilmore MS
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2479-86. PubMed ID: 15980239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Listeria monocytogenes virulence proteins induce surface expression of Fas ligand on T lymphocytes.
    Zenewicz LA; Skinner JA; Goldfine H; Shen H
    Mol Microbiol; 2004 Mar; 51(5):1483-92. PubMed ID: 14982640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma.
    Chuang YH; Fu CL; Lo YC; Chiang BL
    Gene Ther; 2004 Oct; 11(20):1497-505. PubMed ID: 15269717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals.
    Scholz M; Cinatl J
    Med Res Rev; 2005 May; 25(3):331-42. PubMed ID: 15599929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
    Jin Y; Qu A; Wang GM; Hao J; Gao X; Xie S
    Gene Ther; 2004 Jun; 11(12):982-91. PubMed ID: 15042121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.